gemfibrozil and Cardiac Toxicity studies

gemfibrozil and Cardiac Toxicity

gemfibrozil has been researched along with Cardiac Toxicity in 1 studies

Research Excerpts

Excerpt	Relevance	Reference
"Gemfibrozil (GEM) is a lipid-lowering drug with a number of biological properties such as anti-inflammatory and antioxidant activities."	5.51	Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats. ( Aminzadeh, A; Fatemi, I; Goudarzi, M; Haybar, H; Kalantar, M; Khodayar, MJ; Mehrzadi, S, 2019)
"Gemfibrozil (GEM) is a lipid-lowering drug with a number of biological properties such as anti-inflammatory and antioxidant activities."	1.51	Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats. ( Aminzadeh, A; Fatemi, I; Goudarzi, M; Haybar, H; Kalantar, M; Khodayar, MJ; Mehrzadi, S, 2019)

Research

Studies (1)

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Studies

Haybar, H

Goudarzi, M

Mehrzadi, S

Aminzadeh, A

Khodayar, MJ

Kalantar, M

Fatemi, I

Other Studies

1 other study available for gemfibrozil and Cardiac Toxicity

Article	Year
Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109 Topics: Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Doxorubicin; Gemfibrozil; Hypolipidemic Agents	2019

Article

Year

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

Topics: Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Doxorubicin; Gemfibrozil; Hypolipidemic Agents

2019